Brief: ChromoGenics Q4 EBITDA Loss Narrows To SEK 7.6 Million

ChromoGenics AB

19/02/2021 07:44

Feb 19 (Reuters) - ChromoGenics AB  CHRO.ST :
    * Q4 NET SALES SEK 2.0 MILLION VERSUS SEK 8.1 MILLION YEAR
AGO
    * Q4 EBITDA LOSS SEK 7.6 MILLION VERSUS LOSS SEK 20.4
MILLION YEAR
AGO
    * PROPOSES NO DIVIDEND FOR THE 2020 FINANCIAL YEAR
    * ORDER VOLUME FOR Q1 2021 AMOUNTS TO SEK 8.8 (9.5) MILLION

Source text for Eikon:  ID: 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))